Abstract Previous studies have demonstrated activation of the contact system of coagulation and an increase in factor VII coagulant activity (VIIc) when citrated plasma is incubated in the presence of micellar stearate. The products of contact activation, factors Xlla and IXa, were responsible in this system for the activation of factor VII, thereby increasing factor VIIc. To obtain evidence that these in vitro interactions also operate in vivo, factor VIIc was examined in relation to plasma free fatty acid concentrations in five healthy individuals during the consumption of isocaloric high-saturated fat, high-unsaturated fat, and low-fat diets, each taken for 4 weeks in random order and separated by intervals of 12 weeks. For all but the final 3 days of each phase, subjects selected appropriate foods from prepared lists to meet the dietary requirements. Experimental diets of predetermined fat content and composition were fed on days 26 through 28 in each phase. Fat supplied on average 62% of energy in two of the experimental diets and less than 20% of energy in the third. On the final day of each dietary phase, the concentrations of the various free fatty acids and factor VIIc were measured before breakfast and at three 150-minute intervals thereafter. Plasma factor VIIc was, respectively, 6.5% and 13.1% of standard higher on the unsaturated and saturated fat diets than on the low-fat diet. Furthermore, the plasma concentration of stearic acid was strongly associated with factor VIIc (r=.58, /><.0001), and this relation remained significant (P=.OO3) after allowance for the plasma concentrations of palmitic, oleic, and linoleic acids. Plasma factor VII antigen levels were increased on the saturated fat diet but were very similar on the other two diets. These results suggest that the effects of saturated fatty acids observed in vitro on factor VIIc also operate in vivo. (Arterioscler Thromb. 1994;14:214-222 
T he coagulant protein factor VII circulates in human blood at a concentration of about 450 ng/mL, 1 with a half-life of less than 5 hours. 2 About 4 ng/mL is present as the active enzyme factor Vila, 3 -4 and the remainder exists as the zymogen precursor. Coagulant activity is expressed when factor Vila forms a complex with its cofactor, tissue factor (TF), a surface-bound protein present on many cell types beneath the vascular endothelium. The factor VIIa-TF complex then cleaves factor IX and factor X to their active enzymes, thereby initiating the extrinsic pathway of coagulation.
Factor Vila is generated on interaction of the zymogen with factor Xlla of the contact system or factor IXa of the intrinsic pathway, which cleaves the singlechain zymogen to the two-chain enzyme by processes that are independent of TF. 56 Factor Xa will activate factor VII in the presence of TF. 7 The contact system of coagulation is activated in vitro when citrated plasma is exposed to negatively charged surfaces such as kaolin, glass, dextran sulfate, or sulfatide vesicles. 8 ' 9 These surfaces promote the activation of factor XII to factor Xlla, 913 which in turn converts prekallikrein to kal-and factor XIa 17 can generate factor IXa from factor IX, thereby initiating the intrinsic pathway of coagulation. Long-chain saturated fatty acids (including stearic acid) in micellar form can also provide a potent contact surface for the activation of purified factor XII, whereas shorter-chain saturated fatty acids are less effective, and unsaturated fatty acids are ineffective in this regard. 18 When citrated plasma is incubated with micellar stearic acid at a low temperature to reducethe inhibition of factor Xlla and of kallikrein by CT inhibitor, 19 the generation of factor Xlla is accompanied by an increase in factor VII coagulant activity (factor VIIc) due to the activation of factor VII, either directly by factor Xlla or indirectly by way of activation of factors XI and IX. 20 The in vitro incubation of triglyceride-rich plasma with lipoprotein lipase (LPL) to release free fatty acids also produces a prompt and substantial activation of factor XII. 21 Plasma factor VIIc, as measured by a one-stage bioassay, 22 is positively associated with plasma triglyceride levels and dietary fat intake in healthy individuals. 2325 After the ingestion of fat there is an increase in blood triglyceride concentration due to the release of chylomicrons from the gut and of very-low-density lipoprotein (VLDL) from the liver. Core triglyceride in these particles is rapidly hydrolyzed to free fatty acids by the action of LPL, an enzyme bound to the capillary endothelium of various tissues 26 or by hepatic lipase. 1397 (255) 5615 (1032) 63 (7) 1914 ( .
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Each diet was taken for 3 days by five individuals. Values are mean averages (SD).
•Probability values were obtained by ANOVA.
triglyceride. 28 The absence of any concomitant rise in factor VII antigen (factor VIlag) levels 28 indicates that the postprandial increase in factor VIIc is due to conversion of a small amount of factor VII zymogen to factor Vila.
These in vitro and in vivo findings suggest that the effect of fat consumption on factor VIIc might depend on the release of long-chain saturated fatty acids from chylomicrons and VLDL during postprandial lipolysis. On this account, factor VIIc levels have been examined in relation to plasma free fatty acid concentrations in healthy individuals during the consumption of three experimental diets of differing fat content and composition.
Methods
Five healthy adults (4 men and 1 woman) trained in the requirements of dietary studies initially recorded their usual diet over 3 days while continuing their regular daily routine. All food and drink of nutrient value were weighed on an electronic scale and described in sufficient detail to permit conversion of the record to energy and nutrient intake with published tables of food composition. 29 This information was used to construct three experimental and isocaloric diets sufficient to meet energy requirements.
Two dietary periods with high-fat intakes (one high in saturated fats and the other in unsaturated fats) and one with a low-fat intake, each of 4 weeks' duration, were then completed in random order over the following 36 weeks with a washout period of 12 weeks between phases. For all but the final 3 days of each period, subjects selected foods and cooking items from a prepared list. Other lists stated which foods to avoid completely and which items could be eaten in small amounts. Foods encouraged in the high-saturated fat phase were forbidden in the unsaturated fat phase and vice versa. Foods for which the fatty acid composition was unknown were forbidden in all three phases. The objective was to maximize saturated fat intake, unsaturated fat intake, and carbohydrate intake in the respective phases within each individual's tolerance.
To construct the experimental diets to be taken on days 26 through 28 of each phase, lists of foods of known fatty acid composition were given to participants, who indicated their preferences. With this information and knowledge of the individual's energy requirements, 3-day diets were constructed. Fat provided at least 50% of energy in the high-fat phases and less than 20% of energy in the low-fat period (Table 1) . Each subject took all meals at the same time on each day in accordance with their usual routine. Breakfast supplied 50% of daily energy and the other 50% was taken in equal proportions at the remaining meals. Compliance was assured by comparison of the subject's weighed inventory of what had been consumed with the prescribed diet.
On the final day of each phase, a 30-mL blood sample was taken by Vacutainer system immediately before breakfast and on three further occasions at 150-minute intervals. At each venipuncture, 9 mL of blood was added to 1 mL of 0.106 mol/L trisodium citrate in a siliconized glass tube; 10 mL was added to 15 mg disodium EDTA in a plain glass tube; 5 mL was drawn into a siliconized glass tube kept on wet ice and containing an anticoagulant mixture of EDTA, aprotinin, and a thrombin inhibitor supplied by Dietzenbach, FRG; and 5 mL was drawn into a glass tube without anticoagulant. The samples were centrifuged at 2000g for 15 minutes, and the plasma or serum was transferred to 2-mL plastic screw-capped tubes (Nunc) for storage. All samples were stored at -160°C until analysis.
Plasma Lipoproteins
Fresh EDTA plasma was processed for the separation of the d< 1.006 g/mL fraction and the intermediate- 
Concentration and Composition of Fatty Acids
The lipids were extracted from an aliquot of serum 31 and separated by thin-layer chromatography. 32 The bands were visualized with iodine. Those corresponding to unesterified fatty acids, triacylglycerols, and cholesteryl esters were scraped off, and the fatty acids were methylated or transmethylated with boron trifluoride at 85°C to 90°C for 20 minutes. The fatty acid methyl esters were analyzed in a Pye 204 gas-liquid chromatograph with integration using a 5% EG5X phase in a 3-ft glass column at 173°C. The concentration of unesterified fatty acids in the serum was determined by an enzymatic assay (Alpha Laboratories).
Plasma Assays for Factor VII
Factor VHag concentration was determined by an enzymelinked immunosorbent assay method using rabbit anti-human factor VII antibody (Cortecs Diagnostics, Deeside, UK).
Factor VIIc was basically the Northwick Park semiautomated bioassay. 22 Bovine plasma depleted of the vitamin K-dependent proteins was prepared by two successive additions of barium sulfate (50 mg/mL) to fresh oxalated plasma. Factor Vll-deficient plasma was prepared by the addition of a concentrate of human factors II, IX, and X (Blood Products Laboratory, Elstree, UK) to the barium sulfate-adsorbed bovine plasma. The coagulant activity of factors II, IX, and X was 40% to 60%, 40%, and 40% of standard, respectively, whereas factor VIIc was less than 2% of standard. The standard was a pool of citrated normal human plasma diluted to a factor VII potency identical to that of standard plasma from Immuno AG (Vienna, Austria). Duplicate coagulation assays were performed with an Amelung KC 10 coagulometer (American Hospital Supplies Ltd, Oxon, UK) at 37°C. Plasma was diluted by using 50 mmol/L imidazole buffer, pH 7.3, containing 100 mmol/L NaCl and 0.01% NaN 3 (glyoxaline buffer). Duplicate dilutions of the standard plasma were prepared in glyoxaline buffer over the ranges 1:10 to 1:160, and test plasma was diluted 1:40. Rabbit brain thromboplastin (Diagen, Thame, UK) was also diluted 1:32 with glyoxaline buffer to give a clotting time with 1:40 standard plasma of about 30 seconds. To 0.1 mL of a plasma dilution, 0.1 mL factor Vll-deficient plasma and 0.1 mL thromboplastin were added, and the reaction was started by the addition of 0.1 mL of 25 mmol/L CaCl 2 . The mean clotting time for the duplicate assays of each dilution was obtained, and activity in the test plasma was calculated as a percentage of that in standard plasma by means of a microcomputer program. The assays of the standard plasma dilutions were performed at the beginning and end of every batch of test plasma together with two blanks.
When this study was undertaken, direct measurement of factor Vila in plasma was not feasible. Since that time a soluble mutant TF has been described that supports the coagulant activity of factor Vila but not the activation of factor VII zymogen. 3 ' 4 To estimate factor Vila indirectly on the three diets, this mutant TF has been used in a bioassay kindly supplied by Dr James H. Morrissey (Oklahoma Medical Research Foundation) to measure factor Vila concentration and determine its relations with factors VIIc and VHag in a total of 45 subjects (healthy adults, pregnant women, and patients on warfarin therapy). The overall relation was Factor Vila (ng/mL)=0.053 Factor VIIc (% Standard)-0.009 Factor VIlag (% Standard)-0.727.
The coefficient term on factor VIIc was highly significant (/><.0001), whereas that on factor VHag was not (F=.18). The proportion of the variance in factor Vila explained by the regression relation was very high (/? 2 =.842), suggesting its general applicability.
Plasma Factor XII
Factor XII concentration was assayed after its activation by addition of sulfatide vesicles to a dilution of the citrated test plasma and incubation of the mixture in the presence of soybean trypsin inhibitor (Sigma Chemical Co) to inactivate kallikrein. 19 Factor XHa was determined from the initial rate of hydrolysis of the synthetic substrate S-2302 from Kabi Vitram, Uxbridge, UK.
Statistical Methods
A one-way ANOVA was employed to compare the 3-day average intakes of energy and nutrients (Table 1) . To search for differences in blood lipid concentrations and clotting factors between the three dietary phases within individuals, the overall average of each variable across the study and its average value on the final day of each phase were calculated for each of the five subjects. The average on each diet was then expressed as its deviation from the overall average for that subject, so that in effect, each individual acted as his or her own control. Thus, a positive value indicated a relatively high result for that individual, and a negative value a relatively low result. These transformed data were then used in an ANOVA to search for differences in plasma lipoprotein lipid concentrations (Table 2) , percentage composition of serum fatty acids (Table 3) , serum free fatty acid concentrations (Table 4) , and hemostatic factors (Table 5 ) at the end of the three diets. For ease of presentation, however, the absolute means of the individual average values are given by dietary phase in the Tables.
To test whether any differences in measured variables between diets were dependent on the time of day, each individual's result at a specific time point was expressed in terms of its deviation from that individual's time-specific average result across the three diets. These transformed data were then subjected to a repeated-measures ANOVA for interaction between diet and time. Finally, associations between variables (transformed values) were sought by simple correlation analysis. The statistical independence of the associations of factor VIIc with specific plasma free fatty acid levels was tested by stepwise multiple linear regression analysis. Table 1 shows good agreement between energy intakes and protein intakes on the three experimental diets. Individual differences in average daily energy intake between any two diets ranged from 53 to 795 kJ (13 to 190 kcal)/d. Total fat intake averaged 62%, 63%, and 15% of energy on the saturated fat, unsaturated fat, and high-carbohydrate diets, respectively. In accordance with the study design, marked differences existed in fatty acid intake on the three diets. All saturated and monounsaturated fatty acids were consumed in greatest quantities on the saturated fat diet (with the exception of the minor component arachidic acid, which was present mostly in the unsaturated fat diet). All polyun- saturated fatty acids were most abundant in the unsaturated fat diet. The shorter-chain saturated fatty acids (C12 through C14) were present in greater quantities in the high-carbohydrate diet than in the unsaturated fat diet. Table 2 presents the mean average lipoprotein lipid concentrations on the final day of each diet. Significant differences between dietary phases were observed for plasma total cholesterol, VLDL cholesterol and triglyceride, LDL cholesterol, and HDL cholesterol concentrations. The differences in total cholesterol and LDL cholesterol were due solely to significantly higher concentrations on the saturated fat diet, the values being similar on the other two diets. Plasma VLDL lipid concentrations were significantly reduced on the unsaturated fat diet, but mean concentrations did not differ significantly between the saturated fat and carbohydrate diets (though tending toward higher values on the latter). Plasma HDL cholesterol had the lowest values on the carbohydrate diet, though the reduction was significant only in comparison with the saturated fat regimen. Chylomicron cholesterol and triglyceride concentrations did not differ significantly between dietary phases. Totai, IDL, LDL, and HDL trigiyceride concentrations did not differ significantly between diets. Table 3 presents the composition of the acyl moieties of the serum cholesteryl ester, triacylglycerol, and free fatty acid fractions on the final day of each diet. Unsaturated fatty acids accounted for about 80% of the acyl groups of the cholesteryl esters on each diet, but linoleic acid had displaced some oleic acid and palmitoleic acid on the unsaturated fat diet. The composition of the acyl chains of the triacylglycerol and the free fatty acid fractions was more influenced by the composition of the dietary fat. Thus, the triacylglycerols were relatively enriched with stearic acid and palmitic acid on the saturated fat diet and with linoleic acid on the unsaturated fat diet. In all three dietary phases, the free fatty acids were relatively enriched with stearic acid and depleted of oleic acid in comparison with the triacylglycerol fraction.
Results
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Serum free fatty acid concentrations on the final day of each dietary phase are shown in Table 4 . Significant differences between all diets were found; the concentration of total free fatty acids was highest on the unsaturated fat phase, intermediate on the saturated fat diet, and lowest on the carbohydrate diet. From the total fatty acid concentration and the percentage contributions of the fatty acids to the total (Table 3) , individual fatty acid concentrations could be calculated. The relatively high total concentration of free fatty acids on the unsaturated fat diet was due to significant increases in all the major fatty acids except for stearic acid, which was in highest concentration on the saturated fat diet. All the major free fatty acids were present in significantly lower concentration on the carbohydrate diet than on the fat-rich diets.
Clotting Factors
Mean average levels of factors VII and XII are shown in Table 5 . Plasma factor VIIc and the estimate of factor Vila were highest on the saturated fat diet, intermediate in the unsaturated fat phase, and lowest on the carbohydrate diet, trends that were highly significant for both variables (/>=.001). Factor VIlag levels did not differ significantly between the unsaturated fat and carbohydrate diet phases but were significantly increased on the saturated fat diet. The measure of factor XII was not significantly different during the three dietary periods. Although the dietary contrasts in factor VIIc increased with time during the day, being most marked in the last blood sample, this trend did not Values are from the final day of the three dietary regimens for five individuals and are mean (SD) percentages. *ANOVAfor differences between diets (n=15). tStatistically significant differences in individual fatty acid content between triacyiglyceroi and free fatty acid fractions.
reach significance (term for diet x time interaction, P=.O9).
Relations Between Plasma Lipids and Factor VIIc
Deviations in factor VIIc on each diet from the individual's overall average were correlated positively with deviations in total cholesterol (r=.7O, / > =.004), LDL cholesterol (r=.77, / > =.001), and HDL cholesterol (r=.61, P=.O15). There were no significant associations between the deviations in factor VIIc and total triglyceride concentration or VLDL triglyceride concentration, but positive associations were observed with deviations in chylomicron triglyceride (r=.53, ^=.04) and LDL triglyceride (r=.8O, P=.0001) concentrations. Deviations in factor VIIc and total free fatty acids were positively associated (r=.56, P=.O3), as were deviations in factor VIIc and the ratio of total free fatty acid level to total triglyceride concentration (r=.61, P=.O16).
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with the time of day. For example, in the morning fasting sample factor VIIc was on average 2.5% of standard above the overall mean for that time point on the saturated fat diet and 2.9% below the overall mean on the carbohydrate diet. The respective figures 450 minutes later were 9.4% above the overall mean and 11.1% below. In the morning fasting sample for stearate, the average value was 18 jumol/L above the overall mean at that time point on the saturated fat diet and 16 /umol/L below that on the carbohydrate diet. At 450 minutes the respective deviations from the overall mean for that time point were 71 ftmol/L above and 78 /xmol/L below. Thus, there was an increasing strength of association between factor VIIc and stearic acid during the day (Table 6 ). The strength of association of factor VIIc with palmitic acid concentrations also increased but was not as strong as for stearic acid. The strongest associations with oleic acid were found in the morning fasting sample and in the final sample 450 minutes later, but no associations were apparent between factor VIIc and linoleic acid ( Table 6 ). The overall associations of factor VIIc with stearic acid and linoleic acid are shown in the Figure. In contrast to factor VIIc (Table 6) , the overall associations between deviations in factor Vllag and each of the serum fatty acid levels were not significant.
Multivariate Analysis
In a stepwise regression analysis (again with all variates expressed as deviations from the individual's average), neither palmitic acid nor oleic acid made any significant contribution to the prediction of factor VIIc after stearic acid had been taken into account. However, stearic acid remained a predictor of factor VIIc (P=.OO3) after oleic acid and palmitic acid had been entered into the regression analysis. Thus only stearic acid concentration appeared to be independently predictive of factor VIIc in these data. This association remained essentially unchanged when allowance was made for plasma lipoprotein lipid concentrations.
Discussion
The present study is the first to provide evidence for an in vivo effect of long-chain saturated fatty acids on factor VIIc, in agreement with the findings of in vitro studies.
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- 20 Stearic acid was taken in the carbohydrate, unsaturated, and saturated fat diets in the ratio of 1.0:1.65:5.45 (Table 1 ). The ratio of serum stearic acid concentrations in the free fatty acid fractions of the three diets was 1.0:2.5:3.0, respectively (Table 4) . Plasma factor VIIc was, respectively, 6.5% and 13.1% of standard higher on the unsaturated and saturated fat diets than on the low-fat diet. Factor Vllag concentrations were not elevated on the unsaturated fat diet compared with the low-fat diet, but on the saturated fat diet there was a significant increase averaging 8.2% of standard. The indirect estimate of factor Vila indicated that its average value was 12.5% and 22.2% higher on the unsaturated and saturated fat diets, respectively, than on the low-fat diet. The relations between factor VII coagulant activity and the concentrations of plasma stearic acid (C18:0) and linoleic acid (C18:2). The subject's overall average of each variable across the study and its average value on the final day of each phase were calculated. Each point represents the deviation (A) of the day's average value from the overall average for the carbohydrate (broken circles), the unsaturated fat (open circles), and the saturated fat (open squares) diets. The broken line is the least-squares regression (n=15;/"=.79;P<.001).
A Plasma free fatty acid concentration (|xM)
Experimental diets of differing fat composition have been consumed for 7 28 or 14 33 days, whereas they were taken for 28 days in the present investigation. Dietary and serum free fatty acids were not measured in the study of Marckmann et al. 33 In the shorter study of Miller et al, 28 stearic acid was taken in two experimental diets in the ratio of 1.0:3.33, and stearate in serum triglyceride did not differ significantly between dietary periods (serum free stearic acid was not measured). The possibility cannot be excluded, therefore, that the failure of factor VIIc to be influenced by dietary fat composition in these earlier studies may have arisen because the design was inadequate to produce appreciable effects on serum free stearic acid levels. Absorbed stearic acid is known to be converted in vivo to oleic acid more efficiently than is palmitic acid, but when taken in large quantities it will increase not only the stearate content of the plasma lipids and free fatty acids, as in this study, but also that of tissue triglycerides and phospholipids. 34 In cross-sectional epidemiological studies positive correlations of factor VIIc with both plasma cholesterol and triglyceride levels are reported, the relation appearing to reside mainly within the triglyceride-rich chylomicron and VLDL fractions of the plasma lipoproteins. 25 In the present study, however, factor VIIc and the indirect measure of factor Vila were appreciably higher on the saturated fat than the low-fat diet even though chylomicron and VLDL lipid levels were no higher on the former than the latter regimen. These results suggest that lipoprotein lipid concentrations per se are not primarily responsible for changes in factor VIIc. This accords with findings in patients with familial LPL deficiency, who have a normal factor VIIc despite a massive hypertriglyceridemia. 21 These patients also have a normal composition and concentration of free fatty acids. 21 Their massive increase in chylomicron and VLDL concentrations imply that free fatty acids would be dispersed on the surface of the lipoproteins at a far lower density than normal, in which state they presumably form a relatively poor contact surface. The present study demonstrated significant positive associations between factor VIIc and the ratio of serum free fatty acids to total triglycerides. Furthermore, factor VIIc was positively associated with the serum total free fatty acid concentration. The significant increase of factor VIlag on the saturated fat diet may be secondary to a sustained activation of factor VII under this regimen, as suggested earlier. 28 Overall, therefore, the evidence from this and other studies suggests that factor VIIc may be influenced by the release of plasma free fatty acids during lipolysis of triglyceride-rich lipoproteins.
During lipolysis, fatty acids are transferred from the core of large lipoproteins to the interface and are, at physiological pH, in the ionized form, 35 thus providing negative charge. Fatty acids on the remnant particles inhibit LPL 3637 but can be transferred to albumin or other membranes to permit further lipolysis. The present results, which show an increase in stearic acid and a decrease in oleic acid in the serum free fatty acid fraction compared with triacylglycerol in all three dietary regimens (Table 3) , may indicate either that stearic acid is preferentially released from core triacylglycerol by LPL or that the relative residence time of stearic acid on remnant surfaces is longer than that of oleic acid. The first possibility is unlikely, since it has previously been shown 38 that the hydrolysis rates of C16:0, C18:0, C18:l, and C18:2 esters in human chyle particles by LPL are the same. Any segregation of saturated fatty acids on remnant particles may be due to the physical properties of these fatty acids that determine a relatively low rate of transfer to albumin or to other membranes. 3940 Chylomicron remnants have longer half-lives after a saturated fat meal than after an unsaturated fat meal. 41 Studies on the activation of purified factor XII suggest 18 that the major requirements for an active contact surface are an appropriate density of negative charges and a static distribution of these charges as assumed at 37°C by micellar long-chain saturated fatty acids (eg, stearic acid). The present results, which show that the plasma concentration of stearic acid was strongly associated with factor VIIc (Figure) , suggested that the putative contact surface in vivo is provided by stearic acid on triglyceride-rich remnants. The significant associations of factor VIIc with palmitic acid and oleic acid in univariate analysis possibly reflected metabolic interrelations between the serum free fatty acids. Consistent with this possibility, in multivariate analysis the associations of factor VIIc with palmitic and oleic acids were not significant when adjusted for stearic acid.
Unlike factor Vila, single-chain factor VII appears to have no activity toward its substrates, factors IX and X, in the presence of TF. 42 > 43 The "priming" of the extrinsic pathway of coagulation through the conversion of some factor VII to factor Vila by the contact system may therefore serve to promote the expression of coagulant activity. Diets rich in saturated fat may shift the hemostatic steady state toward hypercoagulability, with adverse consequences in individuals at risk of acute ischemic events.
